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Abstract
Although IL-17A (commonly referred to as IL-17) has been implicated in the pathogenesis of central nervous
system (CNS) autoimmune disease, its role during CNS bacterial infections remains unclear. To evaluate the broader
impact of IL-17 family members in the context of CNS infection, we utilized IL-17 receptor (IL-17R) knockout (KO)
mice that lack the ability to respond to IL-17, IL-17F and IL-17E (IL-25). In this article, we demonstrate that IL-17R
signaling regulates bacterial clearance as well as natural killer T (NKT) cell and gamma-delta (γδ) T cell infiltrates
during Staphylococcus aureus-induced brain abscess formation. Specifically, when compared with wild-type (WT)
animals, IL-17R KO mice exhibited elevated bacterial burdens at days 7 and 14 following S. aureus infection.
Additionally, IL-17R KO animals displayed elevated neutrophil chemokine production, revealing the ability to
compensate for the lack of IL-17R activity. Despite these differences, innate immune cell recruitment into brain
abscesses was similar in IL-17R KO and WT mice, whereas IL-17R signaling exerted a greater influence on adaptive
immune cell recruitment. In particular, γδ T cell influx was increased in IL-17R KO mice at day 7 post-infection. In
addition, NK1.1high infiltrates were absent in brain abscesses of IL-17R KO animals and, surprisingly, were rarely
detected in the livers of uninfected IL-17R KO mice. Although IL-17 is a key regulator of neutrophils in other
infection models, our data implicate an important role for IL-17R signaling in regulating adaptive immunity during
CNS bacterial infection.
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Introduction
Brain abscesses typically develop following parenchymal
colonization with pyogenic bacteria, such as Staphylococcus
aureus or streptococcus strains [1,2]. Characterized by an
acute edematous response, S. aureus abscesses begin as
localized areas of inflammation, evolving into suppurative
lesions surrounded by a fibrotic capsule. Despite recent
therapeutic advances, brain abscesses are still associated
with significant morbidity and mortality [3]. In addition,
long-term morbidity issues arise in patients recovering
from these infections as a result of the extensive parenchy-
mal damage typically associated with brain abscess forma-
tion, which can manifest as seizures, cognitive deficits, and/
or hemiparesis [3-5]. Because of the ubiquitous nature of
bacteria and the continuous emergence of multi-drug
resistant isolates, such as methicillin-resistant S. aureus
(MRSA), these central nervous system (CNS) infections are
likely to persist [6-8]. Therefore, a better understanding of
the complex host-pathogen interactions that occur during
brain abscess formation is essential for the development of
novel therapies to treat these devastating infections.
The role of T helper 17 (Th17) cells in various inflam-
matory diseases has been a topic of intense investigation
in recent years. Although Th17 cells have been implicated
in the pathogenesis of autoimmune diseases [9-13], they
have also been shown to provide protection against extra-
cellular bacterial infections [14-16]. IL-17A (commonly
referred to as IL-17) is the prototypic cytokine of the
IL-17 family which includes six members, namely IL-17A,
B, C, D, E and F [17-21]. In general, IL-17 plays an import-
ant role in regulating tissue inflammation through the
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induction of proinflammatory cytokines (IL-6, TNF-α and
IL-1β) [22,23], chemokines (CXCL1, CXCL6, CXCL8 and
CCL2) [24], and metalloproteinases [25] from various cell
types, resulting in neutrophil recruitment [9,19,26]. To
date, five IL-17 receptors (IL-17Rs) have been described
(IL-17RA, -B, -C, -D and -E) [22,27-29], with mRNA ubi-
quitously expressed in a wide array of tissues (for example,
lungs, kidney, liver, spleen and brain) [22,27] and multiple
cell types (for example, macrophages, lymphocytes, fibro-
blasts and epithelial cells) [27]. The binding of IL-17 family
members to their corresponding receptors triggers a sig-
naling cascade that elicits cytokine and chemokine produc-
tion. Because IL-17, IL-17E, and IL-17F all signal via the
IL-17R [9,30,31], analysis of IL-17R knockout (KO) mice
represents a way of investigating the broader impact of IL-
17 family member action within the CNS. This was the
rationale employed in the current study.
Among numerous proinflammatory mediators, IL-17
expression is elevated during brain abscess development
[32]. Recent work from our laboratory has demonstrated
that Th17 cells are critical for bacterial containment and
regulation of innate immune cell infiltrates during the
later stages of brain abscess formation [33,34]. This find-
ing suggests that IL-17 may be a key determinant in regu-
lating immune responses during CNS bacterial infection,
but this remains to be determined as Th17 cells secrete
other inflammatory cytokines that can affect the course of
inflammation (for example, IL-22 and IL-27). Therefore,
the current study was designed to evaluate the functional
role of IL-17 family members in brain abscess pathogen-
esis by utilizing IL-17R KO mice. Our data revealed that
IL-17R KO mice displayed higher bacterial burdens than
wild-type (WT) animals, but that this had no effect on
survival following CNS S. aureus infection. In accordance
with the elevated expression of select inflammatory med-
iators (for example, CXCL2 and CXCL9), we also detected
increased gamma-delta (γδ) T cell infiltrates in the brains
of IL-17R KO mice, suggesting a potential compensatory
mechanism in the absence of IL-17R signaling. Most not-
ably, these studies describe an apparent natural killer T
(NKT) cell deficiency in IL-17R KO animals, a novel find-
ing that may offer insights into S. aureus CNS infection,
as well as other peripheral models of infection and injury.
Materials and methods
Mice
IL-17RA KO mice (C57BL/6 background) were obtained
from Amgen (Seattle, WA, USA) [9]. Age- and sex-
matched C57BL/6 mice (Charles River Laboratories,
Frederick, MD, USA, through a contract with National
Cancer Institute) were used as WT controls. All animals
were bred and housed in an AAALAC-accredited animal
facility at the University of Nebraska Medical Center,
provided with food and water ad libitum, and housed
under 12 h light/dark cycles. Brain abscess studies were
performed with mice between 10 and 16 weeks of age.
Generation of experimental brain abscesses
Brain abscesses were induced by intracerebral injection of
a MRSA USA300 strain encapsulated in agarose beads as
previously described [35]. This isolate was recovered from
an otherwise healthy individual who died from a brain
abscess [36]. It is important to note that MRSA strains are
uncommonly observed in community-acquired brain
abscesses [36], whereas they are more prevalent in infec-
tions arising after trauma or neurosurgical procedures
[37], and may differ in virulence compared to methicillin-
sensitive S. aureus (MSSA). Briefly, mice were anesthetized
with an intraperitoneal injection of 2.5% avertin. A 1 cm
longitudinal incision was then made in the scalp to expose
the underlying skull sutures and facilitate the identification
of bregma. A rodent stereotaxic apparatus equipped with a
Cunningham mouse adaptor (Stoelting, Kiel, WI, USA)
was used to implant S. aureus-encapsulated beads into the
striatum, using the following coordinates relative to
bregma: +1.0 mm rostral, +2.0 mm lateral, and -3.0 mm
deep from the surface of the brain. A burr hole was made
and a 10 μl Hamilton syringe fitted with a 26-gauge needle
was used to slowly deliver 2 μl of S. aureus-laden beads
(7 ×103-1×104 colony forming units (CFU)) into the brain
parenchyma. The needle remained in place for 2.5 minutes
following injection to minimize bead efflux and potential
leakage into the meninges. The skin incision was closed
using surgical glue and animals were closely monitored
over the course of each study for clinical indices of infec-
tion. The animal-use protocol, approved by the University
of Nebraska Medical Center Animal Care and Use Com-
mittee, is in accord with the National Institutes of Health
guidelines for the use of rodents.
Quantitation of viable bacteria from brain abscesses
To quantitate the numbers of viable S. aureus associated
with brain abscesses in vivo, serial ten-fold dilutions of
brain abscess homogenates were plated onto modified
trypticase soy agar plates (Becton Dickinson, Sparks,
MD, USA) supplemented with 5% defibrinated sheep
blood (Hemostat Laboratories, Dixon, CA, USA). Titers
were calculated by enumerating colonies and are
expressed as CFU per gram of tissue.
Histological analysis of brain tissues
Immediately ex vivo, brains from IL-17R KO and WT mice
were placed in a cryomold (Fisher Scientific, Fair Lawn,
NJ, USA), embedded in Optimal Cutting Temperature
(OCT) medium (Tissue-Tek, Torrance, CA, USA), and
placed on dry ice until frozen. Cryostat sections (15 μm)
were mounted onto glass slides (Erie Scientific Co., Ports-
mouth, NH, USA) and subjected to H&E staining (Fisher
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Scientific, Fair Lawn, NJ, USA). Images (20×) were col-
lected using a digital slide scanner (Ventana Medical Sys-
tems, Tucson, AZ, USA) and the final images (1×) were
prepared using Ventana Medical Image View Software.
Multi-analyte microbead array for detection of
proinflammatory mediator production
To quantitate inflammatory mediator production in brain
abscess homogenates, a mouse 19-plex microbead suspen-
sion array system was used according to the manufac-
turer’s instructions (Millipore Corporation, Billerica, MA,
USA). This customized array allows for the simultaneous
detection of 19 individual inflammatory molecules in a
single 50 μl sample, including IL-1α, IL-1β, TNF-α, IFN-γ,
IL-6, IL-9, IL-10, IL-12 p40 and p70, IL-15, IL-17, CCL2,
CCL3, CCL4, CCL5, CXCL1, CXCL2, CXCL9 and
CXCL10. Results were analyzed using a Bio-Plex Worksta-
tion (Bio-Rad, Hercules, CA, USA) and adjusted based on
the amount of total protein extracted from abscess tissues
for normalization. The level of sensitivity for most analytes
in the array was 3.2 pg/ml.
Quantitation of abscess-associated cells by fluorescence-
activated cell sorting
To determine whether IL-17R signaling affected innate
and/or adaptive immune cell influx into brain abscesses,
cell populations were quantitated by fluorescence-activated
cell sorting (FACS) as previously described [35,38,39].
Briefly, mice were manually perfused with isotonic PBS,
pH 7.4, for approximately 2 minutes (at approximately
30 ml/minute) to eliminate leukocytes from the vasculature
until the liver appeared blanched. Prior histological analysis
had demonstrated the absence of leukocytes remaining
adherent to the cerebral vascular endothelium and lack of
perivascular cuffing in the Virchow Robin space of
vascular-perfused mice in the brain abscess model (data
not shown). Based on these observations, FACS analysis is
an accurate representation of cells that have invaded the
CNS parenchyma. Following vascular perfusion, the entire
infected hemisphere was collected to recover abscess-
associated cells, which ensured that equivalent tissue
regions were obtained from both IL-17R KO and WT mice
for downstream comparisons of leukocyte infiltrates. Tis-
sues were minced in Hank’s Balanced Salt Solution (HBSS;
Hyclone Laboratories, Logan, UT, USA) supplemented
with 10% Fetal Bovine Serum (FBS; Atlanta Biologicals,
Lawrenceville, GA, USA) and filtered through a 70 μm
nylon mesh cell strainer. At this point, an aliquot of tissue
homogenate from each animal was collected to quantitate
bacterial burdens. The resulting slurry was then digested
for 30 minutes at 37 °C in HBSS supplemented with
0.2 mg/ml collagenase type I and 28 U/ml DNase I (both
from Sigma-Aldrich, St Louis, MO, USA) to obtain a
single-cell suspension. Following enzyme neutralization,
cells were layered onto a discontinuous Percoll gradient
(1.03-1.088 g/ml) and centrifuged at 2,400 rpm for 20
minutes at room-temperature in a swinging bucket rotor.
After centrifugation, myelin debris was carefully aspirated
and the cell interface collected. Following extensive
washes and incubation in Fc Block™ (BD Biosciences, San
Diego, CA, USA), a panel of directly-conjugated anti-
bodies was used for multi-color FACS to identify neutro-
phils (F4/80-, CD45+, Ly6G+), macrophages (F4/80+,
CD45high, Ly6G-), microglia (F4/80+, CD45low-intermediate,
Ly6G-), CD4 T cells (CD3+CD4+), CD8 T cells (CD8a+),
NK cells (NKp46+, NK1.1+), NKT cells (CD3+, NKp46-,
NK1.1+), and γδ T cells (γδTCR+). A recent study from
our laboratory has established that the majority of CD4+
infiltrates during brain abscess development are Th1 and
Th17 cells as shown by CD3+ co-expression [34]. Anti-
bodies were purchased from the following vendors: F4/80-
AlexaFluor488 (AbD Serotec, Raleigh, NC, USA); CD45-
APC, Ly-6G-PE, CD4-AlexaFluor700, CD8a-FITC, and
NK1.1-APC (BD Biosciences); and NKp46-PE and γδTCR-
PE-Cy5 (eBioscience, San Diego, CA, USA). Cells were
analyzed using a BD LSRII (BD Biosciences) with compen-
sation based on the staining of each individual fluoro-
chrome alone and correction for autofluorescence with
unstained cells. Controls included cells stained with isotype
control antibodies to assess the degree of non-specific
staining. Analysis was performed using BD FACSDiva™
software (BD Biosciences) with cells gated on the total
leukocyte population. Results are presented as the absolute
number of cells recovered from each brain, with
normalization to adjust for the recovery of different cell
numbers from the two mouse strains.
Statistics
Significant differences in bacterial titers, immune cell
infiltrates, and proinflammatory mediator expression be-
tween IL-17R KO and WT mice at a particular time
point were determined using a paired Student’s t-test
(SPSS Science, Chicago, IL, USA). A P-value of less than
0.05 was considered statistically significant.
Results
IL-17 receptor signaling is important for bacterial
clearance during central nervous system S. aureus
infection
Previous work from our laboratory has established signifi-
cant IL-17 production and Th17 infiltrates during brain
abscess development [32,34]. Based on these observations,
it was expected that IL-17 family members would be an
essential component in the developing immune response
to S. aureus brain abscesses, since IL-17A and IL-17E are
known to play a role in granulopoiesis, neutrophil recruit-
ment, and proinflammatory cytokine production in
response to extracellular bacterial infections [40,41]. To
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investigate the functional importance of IL-17 signaling in
the context of CNS infection, brain abscess pathogenesis
was evaluated in IL-17R KO and WT mice. IL-17R signal-
ing was found to be important in controlling bacterial
clearance, as brain abscess tissues of IL-17R KO animals
displayed significantly higher bacterial burdens at days 7
and 14 after infection compared with WT mice (Figure 1).
Despite greater numbers of bacteria present in the brains
of IL-17R KO mice, IL-17R signaling had no significant
effect on survival in this model (Figure 2). Histological ana-
lysis of brain abscesses from IL-17R KO and WT animals
did not reveal any significant alterations in lesion size
between the two groups (Figure 3). In addition, no differ-
ences in edema formation were observed between IL-17R
KO and WT mice at both the gross or histological levels,
and abscess wet tissue weights between both groups were
nearly identical (data not shown). Collectively, these find-
ings suggest that edematous responses are not exaggerated
in IL-17R KO animals following CNS bacterial infection.
Loss of IL-17 receptor signaling results in elevated
proinflammatory mediator production in brain abscesses
The fact that IL-17 is known to induce neutrophil che-
mokine expression, in conjunction with our previous
findings that IL-17-producing CD4+ T cells are the pre-
dominant T cell subset associated with brain abscesses
[42], led us to predict that proinflammatory mediator
production would be attenuated with the loss of IL-17R
signaling. Surprisingly, the expression of several proin-
flammatory mediators was enhanced in IL-17R KO mice.
While IL-17R KO animals predictably had significantly
higher amounts of IL-17 in brain abscess homogenates
(Figure 4A), several other mediators were also elevated
between 7 and 14 days after infection, including IL-1α,
IL-1β, IL-6, CCL3 and CXCL1 (data not shown), as well
as CXCL2 and CXCL9 (Figure 4B,D). These findings
suggest that IL-17R signaling influences inflammatory
mediator production on a more global scale, which may
result from the inability of IL-17R KO mice to efficiently
clear S. aureus from the CNS.
Innate immune cell recruitment into brain abscesses
proceeds in an IL-17-independent manner
A primary role of IL-17 during tissue inflammation is neu-
trophil recruitment, mediated indirectly by the ability of
IL-17 to induce neutrophil chemokine release [9,19,26].
However, the effect of IL-17R signaling on immune cell
influx into the infected CNS is not known. To investigate
this relationship, FACS analysis was performed on brain
Figure 1 IL-17 plays an important role in bacterial clearance
during S. aureus brain abscess formation. Brain abscess tissues
from IL-17 receptor (IL-17R) knockout (KO) and wild-type (WT) mice
(n = 5 to 8 per group) were collected at days 7 and 14 after
infection. Bacterial burdens were then determined by quantitative
culture. Results are expressed as colony forming units (CFU) of S.
aureus per gram of wet tissue weight (mean± SEM) combined from
four independent experiments. *P< 0.05, significant differences in
bacterial titers between IL-17R KO and WT mice.
Figure 2 IL-17 receptor signaling does not affect survival
during central nervous system bacterial infection. Brain
abscesses were induced in IL-17 receptor (IL-17R) knockout (KO) and
wild-type (WT) mice (n = 5 to 8 per group) and animals were
monitored daily after infection. Any moribund mice were euthanized
and dates recorded. Results are presented as the percent (%) survival
and are representative of three independent experiments.
Figure 3 Loss of IL-17 receptor signaling does not affect the
extent of tissue damage during brain abscess development.
Brain tissues from IL-17 receptor (IL-17R) knockout (KO) and wild-
type (WT) mice (n = 6 to 8 per group) were collected at day 7
following S. aureus infection, whereupon tissues were sectioned for
H&E staining to evaluate abscess sizes (arrows). Results are
representative of two independent experiments.
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abscess tissues from IL-17R KO and WT mice. Despite
the important role that IL-17 plays in neutrophil recruit-
ment in other model systems, it was not required during
CNS S. aureus infection since IL-17R KO mice were as
equally capable as WT animals of recruiting these cells to
the site of infection (Figure 5A). The same trend was
observed with macrophage infiltrates (Figure 5B), and no
noticeable differences in the absolute numbers of micro-
glia were observed in these studies (data not shown). Col-
lectively, these results indicate that IL-17R signaling has
minimal effects on innate immune infiltrates during the
course of CNS S. aureus infection.
Figure 4 Loss of IL-17 receptor signaling results in elevated proinflammatory mediator production. Supernatants were collected from
brain abscess homogenates of IL-17 receptor (IL-17R) knockout (KO) and wild-type (WT) mice (n = 5 to 8 per group) at days 7 and 14 after
infection, whereupon IL-17 (a), CXCL2 (b), CCL2 (c) and CXCL9 (d) production was quantitated using multi-analyte bead arrays. Results are
representative of two independent experiments and are presented as the average cytokine/chemokine concentration normalized to the total
amount of protein (mean± SD). *P< 0.05, **P< 0.01, significant differences between IL-17R KO and WT mice.
Figure 5 IL-17 receptor signaling does not influence neutrophil or macrophage recruitment during central nervous system S. aureus
infection. Abscess-associated cells from IL-17 receptor (IL-17R) knockout (KO) and wild-type (WT) mice (n = 5 to 9 per group) were recovered at
the indicated time points after infection and analyzed by flow cytometry to identify neutrophils and macrophages. Results are presented as the
absolute cell number of each population recovered from a total of three independent experiments (mean± SD).
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IL-17 receptor loss differentially regulates T cell subset
infiltration into the infected central nervous system
While previous studies from our laboratory have estab-
lished the presence of IL-17-producing T cells during
brain abscess development [32,34], we have yet to define
how the action of IL-17R influences the accumulation of
various T cell subsets. To address this issue, FACS analysis
was performed on brain abscess tissues from IL-17R KO
and WT animals. As previously demonstrated, CD4+ T
cells were the most frequent T cell infiltrate, with fewer
CD8+ T cells (Figure 6); however, no significant differences
in the absolute numbers of CD4+ or CD8+ T cells were
observed between IL-17R KO and WT mice (Figure 6).
We expanded our analysis to include less frequent brain
abscess T cell infiltrates, including NKT cells and γδ T
cells (Figure 7). Interestingly, NKT cells were significantly
reduced in brain abscesses of IL-17R KO mice throughout
infection (Figure 7A,B), whereas the opposite was true of
γδ T cells, which were significantly elevated compared
with WT animals at day 7 post-infection (Figure 7A). In
contrast, no significant differences in NK cell infiltrates
were detected between groups (data not shown). These
findings suggest that the loss of IL-17R signaling has the
greatest effect on T cell populations that span innate-
adaptive immunity (that is, NKT cells and γδ T cells) in
the context of CNS S. aureus infection.
IL-17 receptor knockout mice exhibit defects in natural
killer T cell populations
Closer examination of our flow cytometry data revealed
the presence of two distinct NK1.1+ populations in the
brain, namely NK1.1high and NK1.1low (Figure 8A,B).
While there was little difference in NK1.1low infiltrates
between groups, the NK1.1high population was signifi-
cantly reduced in IL-17R KO mice, to the point of being
difficult to detect in some experiments (Figure 8C,D).
Based on these findings, we examined whether the failure
to detect NK1.1high infiltrates in brain abscesses resulted
from a defect in recruitment or an inherent absence of
these cells in the periphery. Therefore, the frequency of
NK1.1high cells was examined in the livers of uninfected
IL-17R KO and WT mice as the majority of NK1.1high
cells reside in the liver [43]. Interestingly, NK1.1high cells
were rarely detected in the livers of non-manipulated IL-
17R KO mice (Figure 9). To our knowledge, the require-
ment for IL-17R signaling in populating the liver with
NK1.1high cells has not yet been reported in the literature
and could offer important insights into the relationship
between IL-17R and T cell function in various animal
models. However, since recent studies from our laboratory
have demonstrated that NKTcells do not play a significant
role in regulating immune responses during brain abscess
development (Holley and Kielian, unpublished observa-
tions), this avenue was not pursued further.
Discussion
The role of IL-17 and its receptor have been well studied
in recent years [20,44-46]. Numerous cell types are known
to produce IL-17, including γδ, NKT and CD4+ T cells
[47-49], resulting in robust inflammatory mediator pro-
duction and subsequent neutrophil accumulation [22-
24,49,50]. While IL-17 production is often associated with
various autoimmune disorders [9-13], the cytokine is also
known to exert protective effects during extracellular bac-
terial infections [14-16]. Our previous studies have demon-
strated significant IL-17 production during brain abscess
development [32-34], and Th17 cells represent a predom-
inant CD4+ infiltrate. To understand the functional im-
portance of IL-17 and related family members on brain
abscess pathogenesis, we examined disease progression in
IL-17R KO mice. Given its key role in neutrophil recruit-
ment, and our previous findings that neutrophils are essen-
tial for survival during S. aureus abscess formation [51], we
expected that loss of IL-17R signaling would result in a
diminished capacity to control infection. To some extent
this prediction was correct, as shown by the fact that IL-
17R KO mice exhibited delayed bacterial clearance com-
pared with WT animals. However, despite elevated bacter-
ial burdens, survival rates were similar between IL-17R KO
and WT animals. An explanation for the latter observation
is that, despite the defect in IL-17R function, IL-17R KO
mice were as effective as WT animals in recruiting innate
immune cells into the infected brain. As established by
previous studies in our laboratory [51], a correlation exists
between the degree of neutrophil infiltration and bacterial
Figure 6 IL-17 receptor loss has no effect on T cell recruitment
into brain abscesses. Abscess-associated cells from IL-17 receptor
(IL-17R) knockout (KO) and wild-type (WT) mice (n = 5 to 9 per
group) were recovered at the indicated time points after infection,
and analyzed by flow cytometry to identify CD4+ and CD8+ T cells.
Results are presented as the absolute cell number for each
population recovered from a total of four independent experiments
(mean± SD).
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titers in the brain. Therefore, despite the elevated bacterial
burdens observed in IL-17R KO mice, these animals were
no more likely to succumb to infection than WT mice
since they retained the ability to effectively recruit neutro-
phils into the brain. This suggests that an alternative signal
(or signals) is capable of eliciting neutrophil chemokine
expression and recruitment in the absence of IL-17R
action. Indeed, many redundant mechanisms exist to en-
sure efficient pathogen recognition and clearance by the
host immune system, with possible candidates including
complement split products (for example, C3a, C5a) and
bacterial components (for example, formylated peptides).
Therefore, while IL-17R signaling is not essential for sur-
vival following CNS S. aureus challenge, it does appear to
be important in controlling bacterial burdens, though the
exact mechanism(s) of action remains to be determined.
Differentiation of naïve CD4+ T cells into T helper or
effector cells relies heavily on the inflammatory milieu. As
we have previously demonstrated, Th17 infiltrates are
present in S. aureus-induced brain abscesses [33,34,42].
Based on the understanding that IL-17 plays a pivotal role
in inducing and maintaining an effective immune
response, as well as results from others utilizing IL-17R
KO mice [9,52], we expected that a loss in IL-17R function
would result in decreased proinflammatory mediator
expression during CNS S. aureus infection. On the con-
trary, most mediators that we measured were elevated in
brain abscesses of IL-17R KO animals. In particular,
potent neutrophil chemoattractants, such as CXCL1 and
CXCL2, were increased in IL-17R KO mice, possibly act-
ing to compensate for the loss of IL-17R signaling. Evi-
dence to support this possibility is provided by the fact
that neutrophil infiltrates were similar in both IL-17R KO
and WT animals. It is important to note that IL-17R KO
mice have been shown to exhibit fewer circulating neutro-
phils in other studies [9,52]. This discrepancy may be
explained by the fact that most reports using IL-17R KO
mice have focused on peripheral sites of inflammation in
Figure 7 IL-17 receptor signaling differentially regulates natural killer T (NKT) and gamma-delta (γδ) T cell recruitment into brain
abscesses. Abscess-associated cells from IL-17 receptor (IL-17R) knockout (KO) and wild-type (WT) mice (n = 5 to 9 per group) were recovered at
the indicated time points after infection and analyzed by flow cytometry to identify NKT (NK1.1+/NKp46-; red) and gamma-delta (γδ) T cells
(γδTCR+; green). Fluorescence-activated cell sorting (FACS) contour plots are presented to demonstrate the different population densities and
distributions between IL-17R KO and WT mice at days 7 (a) and 14 (b). These populations were quantified and results presented as the absolute
cell number of each population at days 7 (c) and 14 (d) following infection from a total of four independent experiments (mean± SD). *P< 0.05,
significant differences in abscess-associated T cell subsets between IL-17R KO and WT mice.
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the spleen, liver and lungs, whereas we examined a unique
tissue compartment in the CNS. Since IL-17RA is respon-
sible for transducing signals emanating from IL-17, IL-17 F
and IL-17E (IL-25) [20,29], we are not able to definitively
assign the biological actions of IL-17R signaling to one spe-
cific IL-17 family member. Nonetheless, the approach to
begin studying IL-17R KO animals was preferred since it
represented a more global means of assessing IL-17 iso-
form involvement, whereupon the identification of specific
family members can be assessed in future studies that are
outside the scope of the current report.
While the early innate response is crucial to controlling
bacterial burdens and recruiting effector cells into the
brain during abscess formation, equally important is the
developing adaptive immune response [34]. As we and
others have previously shown [33,34,53], CD4+ T cells are
detected in brain abscesses as early at 3 days after infec-
tion and our recent study [34], using T cell adoptive trans-
fers into TCR αβ KO mice, revealed that both Th1 and
Th17 cells are important for effective bacterial clearance
during brain abscess development. To address whether
Th1 or Th17 infiltrates were altered in the context of
IL-17R loss, we performed intracellular cytokine staining
for IL-17 and IFN-γ. No significant differences in the pro-
portions of CD3+CD4+ Th1 or Th17 cells were observed
in the brains of WT and IL-17R KO mice at day 7 follow-
ing S. aureus infection (data not shown) when peak T cell
infiltrates were apparent (Figure 6). As the absolute num-
bers of CD4+ T cells in the brains of IL-17R KO and WT
mice were similar at day 7 post-infection, the increased
IL-17 levels observed in KO mice are likely to be attribu-
ted to either cytokine accumulation based on receptor
Figure 8 Differential expression of NK1.1 in abscess-associated tissue. Abscess-associated cells from IL-17 receptor (IL-17R) knockout (KO)
and wild-type (WT) mice (n = 5 to 9 per group) were recovered at days 7 (a) and 14 (b) after infection and analyzed by flow cytometry to identify
NK1.1high and NK1.1low infiltrates. Representative contour plots depict differences in population densities between IL-17R WT and KO mice. Post-
analysis gates were drawn around NK1.1high (red) and NK1.1low (green) populations in the top panel (NK1.1 versus NKp46) and corresponding
populations can be seen in the bottom panel (NK1.1 versus γδ TCR). These populations were quantified at days 7 (c) and 14 (d) after infection
and are expressed as the absolute number of each population recovered from four independent experiments (mean± SD). **P< 0.01, significant
differences between IL-17R KO and WT mice.
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absence or, alternatively, the significantly larger population
of γδ T cells infiltrating the CNS of IL-17R KO mice that
can also produce IL-17.
Most notable was the effect of IL-17R loss on non-
traditional T cell populations, specifically NKT cells and
γδ T cells, which are often considered transitional cells
because of their ability to bridge innate and adaptive im-
munity [54,55]. Our studies found that γδ T cell infiltrates
were significantly increased in brain abscesses of IL-17R
KO mice compared with WT animals at day 7 after infec-
tion, and remained elevated through day 14. Cell surface
expression of Toll-like receptor (TLR)2 on γδ T cells [56],
coupled with their ability to rapidly produce proinflamma-
tory cytokines such as IL-17 [57,58] and IFN-γ [59,60],
makes γδ T cells adept as early responders to bacterial
infection. However, the role that γδ T cells play during
brain abscess development in the context of IL-17R loss
remains uncertain.
NKT cells represent a unique lymphocyte population
that expresses NK cell markers as well as a semi-
invariant T cell receptor [43,61] and NKT cell infiltrates
are detected during early brain abscess development
[42]. Initial studies reported significantly decreased accu-
mulation of NKT cells in brain abscesses of IL-17R KO
mice compared with WT animals at both days 7 and 14
following CNS infection. Further analysis revealed the
presence of two distinct NK1.1+ populations, namely
NK1.1high and NK1.1low. The NK1.1low-expressing popu-
lation was found to co-express the γδ TCR, indicating
that these cells were likely to be γδ T cells, albeit only a
fraction of the total γδ T cell population, as the absolute
numbers of NK1.1+, γδ TCR+ cells remained relatively
constant throughout infection, with little difference
noted between IL-17R KO and WT mice. Additionally,
both the NK1.1high and NK1.1low cells in the brain were
found to be predominantly CD4- (data not shown). As
these preliminary studies were designed to examine fun-
damental differences in infiltrating immune cells in IL-
17R KO versus WT mice, a more comprehensive ana-
lysis would be required to determine whether these
NK1.1+ populations represent classical or invariant NKT
cells. However, although NKT cells represent a sizable
immune cell infiltrate during early brain abscess devel-
opment, recent studies from our laboratory utilizing
CD1d KO mice, which lack all NKT cell subsets, failed
to reveal any distinct phenotypes during CNS infection
(Holley and Kielian, unpublished observations).
An intriguing finding of the current study was that
NK1.1high cell infiltrates were essentially absent in brain
abscesses of IL-17R KO mice. We looked at whether
defective NK1.1high cell recruitment into brain abscesses
in IL-17R KO animals resulted from impaired trafficking
into the CNS or if these cells were absent in the periphery.
While NK1.1+ cells are broadly distributed in mice, they
are most frequent in the liver [43,61,62]. To determine
whether IL-17R KO mice demonstrated an inherent defi-
ciency in NK1.1high cells, we analyzed liver tissues from
uninfected IL-17R KO and WT animals. Interestingly,
Figure 9 NK1.1high cells are rarely detected in the livers of IL-17 receptor knockout mice. Cells were collected from the livers of uninfected
IL-17 receptor (IL-17R) knockout (KO) and wild-type (WT) mice (n = 3 to 6 per group) and analyzed by flow cytometry to identify NKT and
gamma-delta (γδ) T cells. Fluorescence-activated cell sorting (FACS) contour plots are presented to demonstrate the different population densities
and distributions between IL-17R WT and IL-17R KO mice. The total NK1.1+ population is indicated in red, whereas the total γδ TCR+ population is
indicated in green. Plots are representative of three independent experiments.
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FACS analysis revealed few NK1.1high-expressing cells in
IL-17R KO mice under resting conditions. Unlike the
CD4- NK1.1high infiltrate in brain abscesses of WT ani-
mals, NK1.1high cells in the livers of WT mice were pre-
dominantly CD4+ (data not shown). Several studies have
described the immense diversity in NKT cell phenotypes
and functionality [63-66]. The differential expression of
CD4 on NK1.1+ cells isolated from the brain and liver of
mice suggests that these may represent two functionally
and potentially developmentally distinct populations. To
our knowledge, this is the first report describing a paucity
of NK1.1high cells in IL-17R KO mice; a finding that could
offer valuable insights into their function during both
CNS and systemic diseases.
In summary, we have described an important role for
IL-17R signaling in controlling bacterial burdens during
CNS S. aureus infection. Despite their defect in S. aureus
clearance, IL-17R KO mice were no more likely to
succumb to infection than WT animals. This could be
attributed to increased inflammatory infiltrates (that is, γδ
T cells) in brain abscess of IL-17R KO mice, correspond-
ing with an ability to control infection in an IL-17-
independent manner. Finally, we describe for the first time
an inherent rarity of NK1.1high-expressing cells in unin-
fected IL-17R KO mice. From a broader perspective, this
finding could have important implications, as IL-17R KO
mice are commonly used to study both autoimmune and
infectious diseases [67,68].
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